| Literature DB >> 26010770 |
Ze-Min Ling1, Ying Tang1, Ying-Qin Li1, Hao-Xuan Luo1, Lin-Lin Liu1, Qing-Qiang Tu2, Li-Hua Zhou1.
Abstract
Brachial plexus root avulsion (BPRA) leads to dramatic motoneuron death and glial reactions in the corresponding spinal segments at the late stage of injury. To protect spinal motoneurons, assessment of the affected spinal segments should be done at an earlier stage of the injury. In this study, we employed 18F-FDG small-animal PET/CT to assess the severity of BPRA-induced cervical spinal cord injuries. Adult Sprague-Dawley rats were randomly treated and divided into three groups: Av+NS (brachial plexus root avulsion (Av) treated with normal saline), Av+GM1 (treated with monosialoganglioside), and control. At time points of 3 day (d), 1 week (w), 2 w, 4 w and 8 w post-injury, 18F-FDG micro-PET/CT scans and neuropathology assessments of the injured spinal roots, as well as the spinal cord, were performed. The outcomes of the different treatments were compared. The results showed that BPRA induced local bleeding and typical Wallerian degeneration of the avulsed roots accompanied by 18F-FDG accumulations at the ipsilateral cervical intervertebral foramen. BPRA-induced astrocyte reactions and overexpression of neuronal nitric oxide synthase in the motoneurons correlated with higher 18F-FDG uptake in the ipsilateral cervical spinal cord during the first 2 w post-injury. The GM1 treatment reduced BPRA-induced astrocyte reactions and inhibited the de novo nNOS expressions in spinal motoneurons. The GM1 treatment also protected spinal motoneurons from avulsion within the first 4 w post-injury. The data from this study suggest that 18F-FDG PET/CT could be used to assess the severity of BPRA-induced primary and secondary injuries in the spinal cord. Furthermore, GM1 is an effective drug for reducing primary and secondary spinal cord injuries following BPRA.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26010770 PMCID: PMC4444271 DOI: 10.1371/journal.pone.0127685
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Higher 18F-FDG accumulation in ipsilateral cervical intervertebral foramen and spinal cord was reduced by GM1 treatment in the rats with a right brachial plexus root avulsion injury at 3 d, 1 w, 2 w, 4 w, and 8 w post-injury.
(A): C7–C8 spinal segment located in sagittal (A,a), axial (A,b), and coronal (A,c) sections [P = Posterior, A = Anterior, R = Right, L = Left, S = Superior, I = Inferior]. (B): Time-dependent serial PET/CT scans of C7–C8 spinal segments of the rats in the Sham (sham control), Av+NS (BPRA with normal saline treatment), and Av+GM1 (BPRA with GM1 treatment) groups. Images of the C7–C8 spinal segments are shown in cross sections (A,b). The scale was set according to signal intensity. (C-D): Semiquantitative analysis of the I/C ratios of F-FDG uptake at the cervical intervertebral foramen (C) and spinal cord (D). *p < 0.05 compared to the Sham group, #p < 0.05 compared to the Av + GM1 group. I/C ratio = mean counts per pixel of lesion ROIs/mean counts per pixel of the contralateral normal area [indicated by the white dotted semi-oval or the white dotted circle in Fig 1B]. (E): The histology of the distal ends of the avulsed and un-avulsed C8 nerve roots with HE staining. In the sham control rats, the dorsal and ventral roots were completely separated by the nerve sheaths, and the axons were well organized. In rats from the Av+NS and Av+GM1 groups, the arrangement of the dorsal and the ventral roots disappeared, and bleeding, degenerated axons, and fibrosis masses occurred. There was comparatively less bleeding and earlier gliosis in the Av+GM1 group. Scale bar = 50 μm. [DR: dorsal roots; VR: ventral roots; Ve: vessel].
Fig 2GM1 treatment reduces astrocyte reactions and inhibits nNOS expression in affected motoneurons (MNs) in the ipsilateral ventral horns of C7–C8 spinal cord at 2 w and 4 w post-injury.
Scale bar = 200 μm. (A-F): Representative microphotographs showing avulsion-induced astrocyte reactions in the ventral horns with GFAP immunohistochemistry. (G-L): Representative microphotographs showing nNOS expression in ventral horn motoneurons with nNOS immunofluorescence. (M): Histograms showing average GFAP densities in the ventral horn as the ratio of the ipsilateral ventral horn percentage to the percentage of the contralateral ventral horn in each section of BPRA-injured or GM1-treated spinal cords. The density of the GFAP immunostaining significantly increased in the Av+NS group compared to the Av+GM1 group. (N) The number of nNOS-positive motoneurons of the injured spinal cord significantly increased in the Av+NS group compared to the Av+GM1 group. #p < 0.05 compared to the Av+GM1 group, * p < 0.05 compared to the Sham group.
Fig 3GM1 enhanced the survival of injured motoneurons and the correlation of 18F-FDG uptake with the GFAP density and number of nNOS-positive and surviving motoneurons in the ipsilateral C7–C8 spinal cord.
(A–I) Representative microphotographs of the surviving motoneurons stained with neutral red in the C8 spinal ventral horns at 2 w, 4 w and 8 w post-injury. Scale bar = 200 μm. J: Quantitative study of the survival rate showed significantly lower survival for motoneurons in the Av+NS group and the Av+GM1 group. The survival rate was significantly higher in the GM1-treated rats compared to the avulsion group. *p < 0.05 compared to the Sham group, #p < 0.05 compared to the Av+GM1 group. K: Correlation analysis between the I/C ratio of the ipsilateral sides of the spinal cord with GFAP intensity, nNOS-positive motoneurons, or surviving motoneurons in the ipsilateral ventral horns at 2 w and 4 w post-injury. The I/C ratio in the F-FDG uptake was positively correlated with the density of the GFAP intensity (R = 0.672, P<0.001) and the number of nNOS positive motoneurons in the ipsilateral ventral horn (R = 0.525, P<0.05), but the ratio was not correlated with the survival ratio for ipsilateral ventral horn motoneurons (R = 0.086, P>0.05).